₹0.13
(Market cap
₹17 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
--
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-5 Cr
-
ROE
0 %
-
ROCE
-36.8 %
-
Industry P/E
52.5
-
EV/EBITDA
-162.8
-
Debt to Equity
-1.1
-
Book Value
₹--
-
EPS
₹-2.1
-
Face value
10
-
Shares outstanding
23,825,000
10 Years Aggregate
CFO
₹228.00 Cr
EBITDA
₹-167.85 Cr
Net Profit
₹-210.17 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Kobo Biotech
| 197.1 | 128.3 | 200.8 | 189.8 | 41.1 | 5.8 | -3.9 |
|
BSE Healthcare
| 11.0 | 0.7 | 14.0 | 11.9 | 24.3 | 14.1 | 12.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Kobo Biotech
| -44.8 | 39.5 | -16.7 | -64.0 | 23.5 | 160.6 | -50.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Kobo Biotech
|
7.1 | 16.9 | 0.0 | -5.0 | -- | -- | -- | -- |
| 1,076.0 | 13,133.1 | 2,551.8 | 564.5 | 28.3 | 18.4 | 23.3 | 3.9 | |
| 517.3 | 8,975.1 | 947.3 | 247.8 | 28.5 | 18.9 | 36.2 | 6.6 | |
| 1,335.4 | 13,960.0 | 1,054.9 | 256.3 | 27.8 | 13.7 | 53.5 | 6.9 | |
| 1,795.0 | 34,077.0 | 9,203.5 | 941.3 | 15.4 | 19.6 | 36.9 | 6.9 | |
| 17,192.0 | 21,962.6 | 2,023.0 | 364.0 | 23.9 | 20.8 | 60.3 | 11.7 | |
| 958.4 | 4,853.8 | 811.3 | 21.0 | 0.7 | 2.1 | 236.2 | 3.8 | |
| 1,296.5 | 5,974.3 | 649.5 | 121.6 | 23.7 | 13.2 | 51.8 | 6.4 | |
| 833.6 | 9,441.9 | 502.0 | 138.7 | -- | 32.8 | 54.6 | 10.7 | |
| 268.5 | 7,128.4 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 12.1 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Kobo Biotech
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
1993
-
Chairman
Ajit Kamath
-
Managing Director
--
-
Headquarters
Hyderabad, Telangana
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Kobo Biotech
What is the current share price of Kobo Biotech Ltd Today?
The share price of Kobo Biotech Ltd is ₹7.10 (BSE) as of 22-Jun-2026 14:36 IST. Kobo Biotech Ltd has given a return of 41.05% in the last 3 years.
What is the current PB & PE ratio of Kobo Biotech Ltd?
Since, TTM earnings of Kobo Biotech Ltd is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2023
|
0.00
|
-0.04
|
|
2022
|
0.00
|
-0.11
|
|
2021
|
0.00
|
-0.16
|
|
2020
|
0.00
|
-0.08
|
|
2019
|
0.00
|
-0.16
|
What is the 52 Week High and Low of Kobo Biotech Ltd?
The 52-week high and low of Kobo Biotech Ltd are Rs 7.10 and Rs 1.99 as of 22-Jun-2026.
What is the market cap of Kobo Biotech Ltd?
Kobo Biotech Ltd has a market capitalisation of ₹ 17 Cr as on 22-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Kobo Biotech Ltd?
Before investing in Kobo Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.